Dept. of Periodontal Mucosal Diseases, The Affiliated Stomatological Hospital, Southwest Medical University; Luzhou Key Laboratory of Oral&Maxillofacial Reconstruction and Regeneration, Southwest Medical University, Luzhou 646000, China.
Hua Xi Kou Qiang Yi Xue Za Zhi. 2024 Apr 1;42(2):192-206. doi: 10.7518/hxkq.2024.2023280.
This study aimed to explore the expression trends of innate immune cells and immune-checkpoint molecules validated by data calculation in the process of oral mucosal carcinogenesis, as well as to explore methods of suppressing oral mucosal carcinogenesis based on immunotherapy by predicting their interactions. 1) The cancer genome atlas (TCGA) database comprehensively scores immune cells and immune-checkpoint molecules in the process of oral mucosal carcinogenesis and screens out intrinsic immune cells and immune-checkpoint molecules that interfere with tumor immune escape. 2) Clinical patient blood routine data were collected for the statistical analysis of peripheral blood immune cells during the progression of oral mucosal carcinogenesis. Immune cells in peripheral blood that may affect the progression of oral mucosal carcinogenesis were screened. 3) Immunohistochemical staining was performed on intrinsic immune cells and immune-checkpoint molecules validated based on data calculation in various stages of oral mucosal carcinogenesis. 4) Special staining was used to identify innate immune cells in various stages of oral mucosal carcinogenesis based on data-calculation verification. 5) Survival analysis was conducted on intrinsic immune cells and immune-checkpoint molecules validated based on data calculation during the process of oral mucosal carcinogenesis. The association of intrinsic immune cells and immune-checkpoint molecules with the prognosis of oral squamous cell carcinoma was verified.
The expression of monocytes and neutrophils increased during the process of oral mucosal carcinogenesis. The expression of eosinophils showed a single peak trend of up and down. The expression of mast cells decreased. In the process of oral mucosal carcinogenesis, the expression of the immune-checkpoint molecules cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and programmed cell death-ligand (PD-L1) increased. The expression trends of monocytes, neutrophils, and eosinophils were positively correlated with those of CTLA4 and PD-L1 immune-checkpoint molecules. The expression trend of mast cells was negatively correlated with the expression of CTLA4 and PD-L1. Monocytes, neutrophils, and eosinophils may promote tumor immune escape mediated by CTLA4 and/or PD-L1, thereby accelerating the progression of oral mucosal carcinogenesis. Mast cells may inhibit tumor immune escape mediated by CTLA4 and/or PD-L1, delaying the progression of oral mucosal carcinogenesis.
Therefore, interference with specific immune cells in innate immunity can regulate the expression of CTLA4 and/or PD-L1 to a certain extent, inhibit tumor immune escape, and delay the progression of oral mucosal carcinogenesis.
本研究旨在通过数据计算探索固有免疫细胞和免疫检查点分子在口腔黏膜癌变过程中的表达趋势,并预测它们的相互作用,探索基于免疫疗法抑制口腔黏膜癌变的方法。1)癌症基因组图谱(TCGA)数据库全面评估口腔黏膜癌变过程中免疫细胞和免疫检查点分子的评分,并筛选出干扰肿瘤免疫逃逸的固有免疫细胞和免疫检查点分子。2)收集临床患者血常规数据,对口腔黏膜癌变过程中外周血免疫细胞进行统计分析,筛选可能影响口腔黏膜癌变进程的外周血免疫细胞。3)对基于数据计算验证的固有免疫细胞和免疫检查点分子进行免疫组织化学染色。4)基于数据计算验证对口腔黏膜癌变各阶段固有免疫细胞进行特殊染色。5)对基于数据计算验证的固有免疫细胞和免疫检查点分子在口腔黏膜癌变过程中进行生存分析,验证固有免疫细胞和免疫检查点分子与口腔鳞状细胞癌预后的关系。
在口腔黏膜癌变过程中,单核细胞和中性粒细胞的表达增加。嗜酸性粒细胞的表达呈先升后降的单峰趋势。肥大细胞的表达减少。在口腔黏膜癌变过程中,细胞毒性 T 淋巴细胞相关蛋白 4(CTLA4)和程序性细胞死亡配体 1(PD-L1)等免疫检查点分子的表达增加。单核细胞、中性粒细胞和嗜酸性粒细胞的表达趋势与 CTLA4 和 PD-L1 免疫检查点分子的表达趋势呈正相关。肥大细胞的表达趋势与 CTLA4 和 PD-L1 的表达呈负相关。单核细胞、中性粒细胞和嗜酸性粒细胞可能通过 CTLA4 和/或 PD-L1 促进肿瘤免疫逃逸,从而加速口腔黏膜癌变的进展。肥大细胞可能通过 CTLA4 和/或 PD-L1 抑制肿瘤免疫逃逸,从而延缓口腔黏膜癌变的进展。
因此,干扰固有免疫中的特定免疫细胞可以在一定程度上调节 CTLA4 和/或 PD-L1 的表达,抑制肿瘤免疫逃逸,延缓口腔黏膜癌变的进展。